- Home
- INKT vs STEC Comparison
INKT vs STEC Comparison
Compare INKT & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- STEC
- Stock Information
- Founded
- INKT 2017
- STEC 2006
- Country
- INKT United States
- STEC Hong Kong
- Employees
- INKT N/A
- STEC N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- STEC
- Sector
- INKT Health Care
- STEC
- Exchange
- INKT Nasdaq
- STEC NYSE
- Market Cap
- INKT 75.7M
- STEC 63.8M
- IPO Year
- INKT 2021
- STEC 2021
- Fundamental
- Price
- INKT $16.63
- STEC $0.72
- Analyst Decision
- INKT Hold
- STEC
- Analyst Count
- INKT 3
- STEC 0
- Target Price
- INKT $37.50
- STEC N/A
- AVG Volume (30 Days)
- INKT 2.9M
- STEC 12.8K
- Earning Date
- INKT 08-12-2025
- STEC 08-05-2025
- Dividend Yield
- INKT N/A
- STEC N/A
- EPS Growth
- INKT N/A
- STEC N/A
- EPS
- INKT N/A
- STEC N/A
- Revenue
- INKT N/A
- STEC $10,672,000.00
- Revenue This Year
- INKT N/A
- STEC $9,392.20
- Revenue Next Year
- INKT N/A
- STEC N/A
- P/E Ratio
- INKT N/A
- STEC N/A
- Revenue Growth
- INKT N/A
- STEC N/A
- 52 Week Low
- INKT $4.56
- STEC $0.20
- 52 Week High
- INKT $76.00
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- INKT 49.44
- STEC 38.03
- Support Level
- INKT $18.54
- STEC $0.70
- Resistance Level
- INKT $20.25
- STEC $0.80
- Average True Range (ATR)
- INKT 8.24
- STEC 0.08
- MACD
- INKT -1.13
- STEC 0.00
- Stochastic Oscillator
- INKT 13.41
- STEC 34.03
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.